about
Progress and problems in understanding and managing primary Epstein-Barr virus infectionsAnti-human immunodeficiency virus agent 3'-azido-3'-deoxythymidine inhibits replication of Epstein-Barr virusActivity of penciclovir against Epstein-Barr virusSevere thrombocytopenia as a complication of acute Epstein-Barr virus infection.Antiviral agents for infectious mononucleosis (glandular fever).Emerging therapies for herpes viral infections (types 1 - 8).Achievements and challenges in antiviral drug discovery.Differential effects of acyclovir and 9-(1,3-dihydroxy-2-propoxymethyl)guanine on herpes simplex virus and Epstein-Barr virus in a dually infected human lymphoblastoid cell line.Epstein-Barr virus transformation of human B lymphocytes despite inhibition of viral polymerase.A case report of Epstein-Barr virus-associated retinal vasculitis: successful treatment using only acyclovir therapy.Nobel Lecture. The purine path to chemotherapy.Maribavir inhibits Epstein-Barr virus transcription through the EBV protein kinase.Recent advances in antiherpetic drugs.Epstein-Barr Virus Encephalitis in an Immunocompetent Child: A Case Report and Management of Epstein-Barr Virus Encephalitis.Antiherpes drugs: promises and pitfalls.Inhibitory effects of novel nucleoside and nucleotide analogues on Epstein-Barr virus replication.Epstein-Barr virus infection associated with interstitial nephritis and chronic fatigue.Chemotherapy of herpesvirus infections: present successes and future hopes.Virologic Diagnosis, Viral Monitoring, and Treatment of Epstein-Barr Virus Infectious Mononucleosis.Epstein-Barr viral infectious mononucleosis.The Epstein-Barr virus:host balance in acute infectious mononucleosis patients receiving acyclovir anti-viral therapy.Nobel lecture in physiology or medicine--1988. The purine path to chemotherapy.Antiviral Drugs for EBV.Herpesviridae prevalence in aqueous humor using PCR
P2860
Q24597706-CDAC1866-5E7E-4929-9F4C-29151F267AEAQ28359820-F57C726E-8A89-4391-9D3D-E7811567DC5AQ28367461-6DEDDE76-D4E3-44B1-B2BF-240A7CA3E026Q33360043-EE4080E3-EA92-4529-806A-28382835E06DQ34546950-6CACF730-F702-4413-A9E6-AE8165A64184Q35967376-B105449B-BD15-4B00-896A-638C5F480E36Q36186792-455FFEB0-69BD-4C5B-87FE-791421B01D2AQ36884995-97A4D6D6-F7BC-4134-91BF-9100A572148DQ36904495-7AE5FCBA-2AB2-4BBF-BE45-471EF30EA1D6Q37138554-11D4814E-0EA5-432C-AD00-5CED293F31B8Q38707737-2515DC09-A474-4056-9CD1-99E3C3F352F4Q39187112-97391DEA-6C9F-448A-9701-68197CA79D36Q39318970-B0887151-4DE6-4643-9A65-5ED3A0F94CDDQ40104652-BBB920E0-DC59-4A94-84E5-52C4859EAAADQ40142222-589EFACB-9B00-424A-AAC1-5E51156003CAQ40983855-8893D0FB-50B3-496B-AD81-C5F8B9AB46F2Q41101917-274F683B-B715-4208-AC5C-64F340DC1BFAQ41374911-AF632D55-A032-4CAD-8088-FF492C79EE85Q44902399-E372E7DF-4B2D-4491-8C08-AE583D201BB8Q45082852-5F8CF6E1-01B0-4E3B-86A2-6CE700601469Q45846491-4FB42FFE-4472-4774-8221-091912F0C9D3Q48406876-72069483-F30A-46AB-9B43-D0958BB68E19Q55461330-83CE89E8-5500-42B1-B241-C8B78E350EA6Q58759091-9120EEDF-3F30-4FCC-9148-243F4EA763F9
P2860
description
1983 nî lūn-bûn
@nan
1983年の論文
@ja
1983年論文
@yue
1983年論文
@zh-hant
1983年論文
@zh-hk
1983年論文
@zh-mo
1983年論文
@zh-tw
1983年论文
@wuu
1983年论文
@zh
1983年论文
@zh-cn
name
Acyclovir and Epstein-Barr virus infection.
@en
type
label
Acyclovir and Epstein-Barr virus infection.
@en
prefLabel
Acyclovir and Epstein-Barr virus infection.
@en
P2093
P356
P1476
Acyclovir and Epstein-Barr virus infection.
@en
P2093
P304
P356
10.1093/JAC/12.SUPPL_B.113
P407
P478
12 Suppl B
P577
1983-09-01T00:00:00Z